NCT00326508View on ClinicalTrials.gov

Combination Daclizumab/Denileukin Diftitox to Treat Uveitis

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 11, 2006

Study Completion Date

December 20, 2006

Conditions
Non-infectious Intermediate and Posterior Uveitis
Interventions
DRUG

Daclizumab

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00326508 - Combination Daclizumab/Denileukin Diftitox to Treat Uveitis | Biotech Hunter | Biotech Hunter